Sort
82,697 grants matching “vaccine development”
CELLULAR AND MOLECULAR STUDIES OF BONE MARROW TRANSPLANT
$1,394,463Dana-Farber Cancer Institute · P01 · FY2000 · CA
An Advanced Vaccine Candidate To Prevent Zika Virus Infection
$1,394,457Mark K Slifka · Oregon Health & Science University · R01 · FY2017 · AI
Therapeutic Vaccination for HIV Using VEE Vectors
$1,394,294University Of North Carolina Chapel Hill · P01 · FY2005 · AI
Coronavirus vaccine development
$1,394,275Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Germline targeting influenza immunogens
$1,394,075David Nemazee · Scripps Research Institute, The · R01 · FY2019 · AI
Germline targeting influenza immunogens
$1,394,075David Nemazee · Scripps Research Institute, The · R01 · FY2021 · AI
Germline targeting influenza immunogens
$1,394,075David Nemazee · Scripps Research Institute, The · R01 · FY2020 · AI
Response Therapies for MDR-TB
$1,394,019Ian M Orme · Colorado State University · U01 · FY2006 · AI
CELLULAR AND MOLECULAR STUDIES OF BONE MARROW TRANSPLANT
$1,393,831University Of Michigan At Ann Arbor · P01 · FY2001 · CA
Development of a novel adjuvant for vaccine sparing
$1,393,822Sara Lustigman · New York Blood Center · R01 · FY2013 · AI
Self-amplifying mRNA-based vaccines to elicit VRC01-class bnAbs
$1,393,751Leonidas A Stamatatos · Fred Hutchinson Cancer Center · U19 · FY2024 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$1,393,521Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2017 · AI
Quantifying Heterogeneities in Dengue Virus Transmission Dynamics
$1,393,023Thomas Wallace Scott · University Of California At Davis · P01 · FY2014 · AI
Immunostimulatory Patch To Enhance Biodefense Vaccines
$1,392,960Larry R Ellingsworth · Iomai Corporation · U01 · FY2006 · AI
Development of NHP Models for Infectious Pathogens of Man
$1,392,887Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
SPORE University of Texas M. D. Anderson Cancer Center-Leukemia
$1,392,864Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2018 · CA
Comprehensive SDSU/UCSD Cancer Center Partnership 1 of 2
$1,392,737Elizabeth A Klonoff · San Diego State University · U54 · FY2008 · CA
Development of a Practical Heroin-HIV Vaccine
$1,392,672Gary R. Matyas · Henry M. Jackson Fdn For The Adv Mil/Med · DP1 · FY2013 · DA
Drivers of individual variation in influenza vaccine response and protection from infection
$1,391,997Sarah Cobey · University Of Chicago · R01 · FY2025 · AI
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
$1,391,820Shabaana A. Khader · Washington University · R01 · FY2021 · AI
ANALOGS OF HPMPA FOR TREATMENT OF SMALLPOX
$1,391,660Veterans Medical Research Fdn/San Diego · R01 · FY2005 · AI
Primate Core
$1,391,614Roger A Van Andel · University Of New Mexico · P01 · FY2008 · AI
Office of Research Training and Development
$1,391,592Kathryn Soucy · National Institute Of Allergy And Infectious Diseases · ZIJ · FY2020 · AI
Initial clinical evaluation of attenuated Shigella flexneri 2a live vector expressing enterotoxigenic Escherichia coli antigens, strain CVD 1208S-122.
$1,391,457Wilbur H. Chen · University Of Maryland Baltimore · U01 · FY2020 · AI
Developing computational models to predict the immune response to B. pertussis booster vaccination
$1,391,377Bjoern Peters · La Jolla Institute For Immunology · U01 · FY2020 · AI